Commentary: Pharmacological Validation of ASIC1a as a Druggable Target for Neuroprotection in Cerebral Ischemia Using an Intravenously Available Small Molecule Inhibitor
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.